Clinical Trials Sponsored by Heba Allah Ali Abd El-Halim Mabrouk
Total 2 results
-
Heba Allah Ali Abd El-Halim MabroukTanta UniversityCompleted
-
Heba Allah Ali Abd El-Halim MabroukTanta UniversityUnknown
Sponsors and Collaborators
- Bruce County Paramedic Service
- Equipe MiMes
- Centro di Procreazione Assistita Demetra
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- Mononuclear Therapeutics Ltd.
- AIDS Council of New South Wales
- Chengdu Nuoen Biotechnologies, Inc.
- Nestor Soler Porcar, MD, PhD
- ImproveCareNow (ICN)
- InflaRx GmbH
- Maria Lendorf
- Women and children's hospital of Jiaxing university
- Neuregenix
- Veeda Oncology
- Prestige Biopharma Limited
- North Karelia Hospital District
- BayCare Health System
- Grand Challenges Canada
- Reina Sofia University Hospital
- Bjørgene Omsorgssenter, Haugesund
- View Full List
Medical Conditions
- Tay-Sachs Disease Ganglioside
- Spine Surgeries
- Gullian Barre Syndrome
- Predictors of Atrial Fibrillation Recurrences
- Closure; Foramen Ovale
- Multisystem Proteinopathy
- Painless Hysteroscopy
- Chlamydophila Infections
- Pulmonary Adenocarcinoma
- Epidemic Hemorrhagic Fever
- Endocarditis Infective
- Ewing's Family Tumors
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Fetus or Neonate Affected by External Version Before Labor
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Fracture Dislocation of Cervical Spine
- Skull Base Neoplasms
- Childhood Langerhans Cell Histiocytosis
- Psoriasis, Arthritic
- View Full List
Drug Interventions
- Chemotherapeutic Agent
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Qingkailing injection 40 ml
- Azelastine hydrochloride (BAYR9258)
- Esomeprazole 40mg before
- High dose pantoprazole infusion
- Adapalene Gel 0.3%
- Adriamycin
- Palliative care group first-line scheme
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Redifferentiation with retinoid acid
- EFV +TVA
- Glimepiride
- Vehicle
- Semapimod
- Estradiol+Drospirenone
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Cereport
- Neihulizumab
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Armenia
- Contract Research Organizations in Colombia
- Contract Research Organizations in Denmark
- Contract Research Organizations in Georgia
- Contract Research Organizations in Hungary
- Contract Research Organizations in Israel
- Contract Research Organizations in Malta
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Mexico
- Contract Research Organizations in Qatar
- Contract Research Organizations in Slovakia
- CRO list by country